Literature DB >> 33127430

Routine first-trimester ultrasound screening using a standardized anatomical protocol.

Yimei Liao1, Huaxuan Wen1, Shuyuan Ouyang2, Ying Yuan1, Jingru Bi1, Yong Guan1, Qian Fu1, Xia Yang1, Wenjia Guo1, Yi Huang1, Qing Zeng1, Yue Qin1, Haishan Xiang3, Shengli Li4.   

Abstract

BACKGROUND: First-trimester ultrasound scans were introduced to China for nearly 20 years. The ability of first-trimester ultrasound screening to detect different malformations was variable. A recent systematic review concluded that the use of a standardized anatomic protocol was the most crucial factor to improve the sensitivity of first-trimester ultrasound screening for anomalies. Standardized sectional scans have long been used for routine anatomy screening during the second trimester. However, during the first trimester, most of the previous studies have described the observation of anatomic structures but have not specified clearly the standard sectional views.
OBJECTIVE: We aimed to determine the performance of routine first-trimester scans using a standardized anatomic protocol for detecting structural abnormalities in China. STUDY
DESIGN: This was a large retrospective study involving 59,063 sequential unselected pregnancies. Scans at 11 to 13+6 weeks were performed in a single center during a 7-year span. All fetuses were examined following a predefined protocol for standardized views.
RESULTS: From October 2008 to December 2015, first-trimester scans were performed in 53,349 pregnant women with available outcome. Of these, there were 1578 (3%) pregnancies that presented with at least 1 fetal structural abnormality. The detection rate for first-trimester screening was 43.1% (95% confidence interval, 40.6%-45.5%). Routine first-trimester scans detected 95.6% of abdominal wall defects, 66.3% of nervous system defects, 33.8% of limbs and skeleton malformations, 30.8% of facial abnormalities, 21.2% of urogenital abnormalities, 18.4% of thoracic and lung abnormalities, and 4.1% of gastrointestinal tract abnormalities. During the first trimester, 37.7% of cardiac defects were identified and included 57.9% of major cardiac defects and 2.6% of mild cardiac defects. A robust high detection rate for anencephaly, exencephaly, cephalocele, holoprosencephaly, exomphalos, gastroschisis, Pentalogy of Cantrell, sirenomelia, and body stalk anomaly was achieved during routine first-trimester scans.
CONCLUSION: A standardized anatomic protocol is advised when performing routine first-trimester ultrasound screening. It is recommended that screening for severe structural abnormalities should be extended to the first trimester.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  abnormality; fetus; first trimester; standardized anatomic protocol; ultrasound

Mesh:

Year:  2020        PMID: 33127430     DOI: 10.1016/j.ajog.2020.10.037

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Transient fetal intrathoracic cyst first detected during the 11- to 13-week scan: A resolving pericardial cyst?

Authors:  Waldo Sepulveda; Patricio Stuardo
Journal:  Ultrasound       Date:  2022-01-21

2.  Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.

Authors:  Timothy Wen; Adam S Faye; Kate E Lee; Alexander M Friedman; Jason D Wright; Benjamin Lebwohl; Jean-Frederic Colombel
Journal:  Dig Dis Sci       Date:  2021-05-01       Impact factor: 3.487

3.  Timing of diagnosis of fetal structural abnormalities after the introduction of universal cell-free DNA in the absence of first-trimester anatomical screening.

Authors:  Francesca Bardi; Anne Marie Beekhuis; Marian K Bakker; Ayten Elvan-Taşpınar; Caterina Maddalena Bilardo
Journal:  Prenat Diagn       Date:  2022-09-03       Impact factor: 3.242

Review 4.  Antenatal screening for chromosomal abnormalities.

Authors:  Karl Oliver Kagan; Jiri Sonek; Peter Kozlowski
Journal:  Arch Gynecol Obstet       Date:  2022-03-13       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.